Michael Andoniades

Also, lung cancer causes 2.4x MORE deaths than colorectal cancer each year, making it the #1 cancer killer. 80-90% of lung cancer cases are due to smoking. If you smoked in the past, please take screening seriously.

Colorectal cancer is the #2 cancer killer in the US, behind pancreatic. Yet, it can take 10+ years for a polyp to turn deadly. There's a large window to catch it early.

Which is why early detection is so important!

The impact of physical AI on healthcare: Would you trust a robot to give you an IV?

First responders are at a much higher risk for: • Cancer • Chronic injuries from physical strain • Ongoing exposure to infectious diseases and toxic substances They are a group that could benefit the most from early detection.

Spoke with someone today whose wife is battling Stage IV esophageal cancer. He wishes she had access to early detection much sooner. It was a powerful reminder of why our work at TrueScan matters.

This is so cool

The CMS inclusion of a Category I CPT code for coronary plaque analysis is a game changer. This is going to blast open the doors for adoption.

This may be the best AI commercial we’ve ever made. We worked with one of the best directors in the world to create a wild new ad for Kalshi (Last one hit 100M views) Here’s a breakdown of how we made it in ONE WEEK (prompt included) 👇🏼🧵

Body composition analysis with MRI will eventually replace DXA. DXA will likely remain useful only for a) low-cost body composition scans that don’t require as high sensitivity, and b) bone density measurements – at least until we find a better way to assess bone density

Be sure to check out our blogs: truescanmri.com/blog

U.S. healthcare spending hit $4.9 trillion in 2023 – 5x the size of the global ad industry (where Meta & Google compete). 😳

When caught at stage 1, epithelial ovarian cancer has a five-year survival rate as high as 93%. But for over 70% of patients, the cancer has already spread beyond the pelvis at diagnosis. Despite aggressive treatment, the five-year survival drops to 23–41% at stage 3 and just 5–11% at stage 4.

About 10% of epithelial ovarian cancers have a genetic link. Unfortunately, there’s still no widely accepted screening test for ovarian cancer, which delays diagnosis.

Ovarian cancer staging depends on how far it has spread: stage 1 is limited to the ovary; stage 2 involves nearby pelvic organs like the uterus or fallopian tubes; stage 3 has spread to the abdominal cavity; and stage 4 means it has reached distant parts of the body.

The American Cancer Society recommends lung cancer screening for people aged 50–80 with a 20+ pack-year smoking history. But most people we find with early-stage lung cancer have NEVER smoked. That's all I have to say.